Tomoko Aoki
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Hepatology 61
- Hepatocellular Carcinoma Treatment and Prognosis 59
- Hepatitis C virus research 1
- Oncology 15
- Cancer Immunotherapy and Biomarkers 10
- Inflammatory Biomarkers in Disease Prognosis 5
- Co-authors
- Masatoshi Kudo (23 shared papers)Naoshi Nishida (22 shared papers)Yasunori Minami (21 shared papers)Satoru Hagiwara (20 shared papers)Hiroshi Ida (19 shared papers)Masahiro Morita (17 shared papers)Masahiro Takita (18 shared papers)Kazuomi Ueshima (19 shared papers)
- Journals
- Hepatology Research (14 papers)Liver Cancer (12 papers)Cancers (9 papers)Liver International (6 papers)Scientific Reports (4 papers)
- Partner nations
- JapanItalySouth Korea
In The Last Decade
Tomoko Aoki
75 papers receiving 1.7k citations
Tomoko Aoki's Hit Papers
Peers
Comparison fields: 5 of 51
- Hepatology 1.3k
- Oncology 203
- Epidemiology 196
- Radiology, Nuclear Medicine and Imaging 119
- Cancer Research 30
Countries citing papers authored by Tomoko Aoki
This map shows the geographic impact of Tomoko Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Aoki more than expected).
Fields of papers citing papers by Tomoko Aoki
This network shows the impact of papers produced by Tomoko Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Aoki. The network helps show where Tomoko Aoki may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomoko Aoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 262 | |
| 2 | 2019 | 120 | |
| 3 | 2019 | 114 | |
| 4 | Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study Hit paper breakdown → | 2023 | 112 |
| 5 | 2022 | 103 | |
| 6 | 2021 | 75 | |
| 7 | 2021 | 54 | |
| 8 | 2018 | 46 | |
| 9 | 2020 | 46 | |
| 10 | 2023 | 45 | |
| 11 | 2021 | 43 | |
| 12 | 2022 | 40 | |
| 13 | 2021 | 39 | |
| 14 | 2019 | 38 | |
| 15 | 2020 | 32 | |
| 16 | 2022 | 32 | |
| 17 | 2016 | 27 | |
| 18 | 2022 | 27 | |
| 19 | 2023 | 27 | |
| 20 | 2023 | 25 |
About Tomoko Aoki
Tomoko Aoki is a scholar working on Hepatology, Oncology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 81 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (59 papers), Cancer Immunotherapy and Biomarkers (10 papers), Liver Disease Diagnosis and Treatment (8 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Ultrasound Imaging and Elastography (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Cancer Genomics and Diagnostics (1 paper) and Hepatitis C virus research (1 paper). The work is most often cited by research in Hepatology (1.3k citations), Oncology (203 citations), Epidemiology (196 citations), Radiology, Nuclear Medicine and Imaging (119 citations) and Cancer Research (30 citations). Tomoko Aoki has collaborated with scholars based in Japan, Italy and South Korea. Frequent co-authors include Masatoshi Kudo, Naoshi Nishida, Yasunori Minami, Satoru Hagiwara, Hiroshi Ida, Masahiro Morita, Masahiro Takita, Kazuomi Ueshima, Hirokazu Chishina and Mamoru Takenaka. Their work appears in journals such as Hepatology Research, Liver Cancer, Cancers, Liver International and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.